# Distinct cytokine-producing dendritic cell profiles in females and males with major depressive disorder

**Authors:** Anna-Lena Boller, Jana Freff, Maximilian Bast, Kathrin Schwarte, Udo Dannlowski, Bernhard T. Baune, Stefanie Scheu, Judith Alferink

PMC · DOI: 10.3389/fncel.2026.1753241 · Frontiers in Cellular Neuroscience · 2026-02-09

## TL;DR

The study found that men and women with depression have different immune cell profiles, particularly in dendritic cells that produce specific inflammatory signals, which may explain sex differences in immune-related depression.

## Contribution

The study reveals sex-specific differences in cytokine-producing dendritic cells in major depressive disorder.

## Key findings

- Severely depressed individuals had fewer plasmacytoid DCs and more CD11c+ cDCs in their blood.
- Females with MDD showed elevated IL-23+ cDCs, while males showed increased TNF+, IL-1β+, and IL-6+ cDCs.
- Cytokine-producing DCs, along with age and BMI, predicted depressive symptoms in females but not in males.

## Abstract

Major depressive disorder (MDD) is a revalent and disabling condition increasingly associated with immune dysregulation. Dendritic cells (DCs) are key immune sentinels that shape inflammatory responses and T-cell polarization, including Th17 pathways implicated in depression-related mild inflammation. Given well-documented sex differences in immune responses and cytokine profiles in MDD, differential DC activation may represent a mechanistic link between sex-associated immune cell profiles in depression. However, DCs remain insufficiently characterized in MDD.

We performed an exploratory study using flow cytometry-based immunophenotyping to assess circulating DC subsets, including CD1c+ and CD141+ conventional DCs (cDCs), plasmacytoid DCs (pDCs), and their cytokine profiles in individuals with MDD (n = 55) and healthy controls (HC, n = 32). Stratification by depression severity and sex, together with correlation and multivariate linear regression analyses, and cluster analysis, was used to examine associations between DC subsets and depressive symptom severity in females and males.

Stratification by HAM-D17 scores revealed reduced counts of pDCs and increased frequencies of CD11c+ cDCs in the peripheral blood (PB) of severely depressed participants compared to HC or mildly depressed patients, respectively. Regarding cytokine-producing DCs, sex-stratified analyses showed that frequencies of IL-23+ cDCs were elevated and symptom-associated only in females with MDD compared to sex-matched controls, whereas frequencies of TNF+, IL-1β+, and IL-6+ cDCs were selectively increased in depressed males. Cluster analyses identified distinct female- and male-specific DC subset patterns distinguishing individuals with MDD from HC. Multivariate linear regression revealed a significant predictive contribution of cytokine-producing DCs, together with age and BMI, in females but not in males.

These findings demonstrate sex-specific alterations in cytokine-producing DCs in MDD and a strong association between IL-23+ cDCs and depressive symptom severity, suggesting a key role for these cells in immune dysregulation, particularly in females with depression.

## Linked entities

- **Proteins:** IL37 (interleukin 37), TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6)
- **Diseases:** major depressive disorder (MONDO:0002009), depression (MONDO:0002050)

## Full-text entities

- **Genes:** CD14 (CD14 molecule) [NCBI Gene 929], CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, CLEC4C (C-type lectin domain family 4 member C) [NCBI Gene 170482] {aka BDCA-2, BDCA2, CD303, CLECSF11, CLECSF7, DLEC}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, CCR4 (C-C motif chemokine receptor 4) [NCBI Gene 1233] {aka CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099}, CACNA1C (calcium voltage-gated channel subunit alpha1 C) [NCBI Gene 775] {aka CACH2, CACN2, CACNA1C-IT2, CACNL1A1, CCHL1A1, CaV1.2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, SLC6A4 (solute carrier family 6 member 4) [NCBI Gene 6532] {aka 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TSC22D3 (TSC22 domain family member 3) [NCBI Gene 1831] {aka DIP, DSIPI, GILZ, TSC-22R}, THBD (thrombomodulin) [NCBI Gene 7056] {aka AHUS6, BDCA-3, BDCA3, CD141, THPH12, THRM}, CD1C (CD1c molecule) [NCBI Gene 911] {aka BDCA1, CD1, R7}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, DGAT2L6 (diacylglycerol O-acyltransferase 2 like 6) [NCBI Gene 347516] {aka DC3}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, IDO1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 3620] {aka IDO, IDO-1, INDO}
- **Diseases:** immune (MESH:D007154), IDS (MESH:D016532), CVDs (MESH:D002318), infection (MESH:D007239), insulin resistance (MESH:D007333), weight loss (MESH:D015431), DC (MESH:D054221), viral infection (MESH:D014777), -C (OMIM:211750), hypertension (MESH:D006973), atopic dermatitis (MESH:D003876), immune dysregulation (OMIM:614878), multiple sclerosis (MESH:D009103), chronic (MESH:D002908), Depressed (MESH:D003866), type I diabetes mellitus (MESH:D003922), BD (MESH:D001714), tumor (MESH:D009369), calcification (MESH:D002114), mental disorders (MESH:D001523), neuroinflammation (MESH:D000090862), schizophrenia (MESH:D012559), critical illness (MESH:D016638), glucocorticoid resistance (MESH:C564221), inflammation (MESH:D007249), HC (MESH:D000067329), neurological disorders (MESH:D009461), MDD (MESH:D003865), affective dysregulation (MESH:D021081), metabolic depression (MESH:D008659), autoimmune diseases (MESH:D001327), obese (MESH:D009765), affective disorders (MESH:D019964), immuno (MESH:D000163)
- **Chemicals:** mood stabilizers (-), monensin (MESH:D008985), Alexa647 (MESH:C569686), benzodiazepines (MESH:D001569), tryptophan (MESH:D014364), sodium heparin (MESH:D006493), PBS (MESH:D007854), CO2 (MESH:D002245), LPS (MESH:D008070), cortisol (MESH:D006854), corticosterone (MESH:D003345), brefeldin A (MESH:D020126), progesterone (MESH:D011374), NaN3 (MESH:D019810)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Val66Met

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926495/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926495/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926495/full.md

---
Source: https://tomesphere.com/paper/PMC12926495